No Data
No Data
Private Companies Invested in Sirio Pharma Co., Ltd. (SZSE:300791) up 13% Last Week, Insiders Too Were Rewarded
Sirio Pharma Co., Ltd.'s (SZSE:300791) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Market Still Lacking Some Conviction On Sirio Pharma Co., Ltd. (SZSE:300791)
Sirio Pharma (300791.SZ) specializes in contract research, development, and production of nutritional and health products.
Sirio Pharma (300791.SZ) stated on the investor interaction platform on August 16th that the company's main business is contract R&D and production of nutritional health products. The company develops and produces nutritional health foods according to customer demands for customers to sell at the end. Some of the company's cooperating customers have e-commerce sales channels, which they also use to sell the products produced by the company.
Sirio Pharma (300791.SZ) Director and Deputy General Manager Yao Zhuangmin accumulated shareholding of 0.1152 million shares.
Sirio Pharma (300791.SZ) announced that director and deputy general manager Yao Zhuangmin has accumulated shareholding of 11...
Sirio Pharma (300791.SZ): The gross margin of soft capsule products in the first half of the year declined compared to the whole year last year, mainly due to quarterly fluctuations caused by product structure.
Sirio Pharma (300791.SZ) stated on the investor platform on August 14th that the gross margin of soft capsule products in the first half of the year had declined compared to the previous year. This was mainly due to quarterly fluctuations caused by the product structure. The loss of the US factory has narrowed, decreasing by 9.04 million yuan compared to the same period last year.
No Data
No Data